Empowering appropriate antimicrobial use with rapid diagnostics.

OUR MISSION

The misuse of antibiotics has created a huge global health crisis. The Test Target Treat™ initiative from Alere empowers healthcare professionals to make targeted treatment decisions sooner with rapid diagnostics - reducing inappropriate antimicrobial use and the spread of resistance.

1.0_TTT_dividerbar_440

LATEST NEWS

Alere promotes Antimicrobial Stewardship with “Antibiotics Rapid Action Week”

2016 has seen the threat of Antimicrobial Resistance receive the widespread attention it deserves, including the publication of the landmark O’Neill report… Read More

Antibiotic Resistance is highlighted at U.N. General Assembly

On 21 September 2016, world leaders gathered at the United Nations General Assembly in New York to commit to fighting antimicrobial resistance… Read More

Vietnamese study shows C-reactive protein testing significantly reduces inappropriate use of antibiotics

In the first study to investigate point-of-care CRP in low-income or middle-income countries… Read More

Alere™ Reader achieves In-Vitro Diagnostic (IVD) CE marking in Europe

Alere has achieved In-Vitro Diagnostic (IVD) CE marking in Europe for its new Alere™ Reader*… Read More

RAPID DIAGNOSTIC TESTING

A comprehensive set of diagnotic information, empowering a shift  in prescribing behavior away from the over-use of antibiotics.

1.0_TTT_dividerbar_440
Contact

WANT TO LEARN MORE?

Register for our monthly Test Target Treat e-newsletter alerting you to new educational tools.